|
Market Closed -
Nasdaq
00:00:00 13/11/2026 +03
|
5-day change | 1st Jan Change | ||
| 951.19 USD | -0.86% |
|
+5.35% | +23.23% |
| 11-10 | Regeneron Pharmaceuticals, Inc. - Special Call | |
| 11-09 | Regeneron Pharmaceuticals, Inc. Announces First-In-Human Trial Results For CIDEBsiRNA In MASLD Patients | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Biopharmaceuticals
| Capi. | Sales Growth | Profitability | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
 | 95.45B | |||||
| 1,271B | |||||
| 683B | |||||
| 520B | |||||
| 389B | |||||
| 362B |
Select your edition
All financial news and data tailored to specific country editions
